Related Experiment Video
Updated: May 26, 2026
05:28
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
suPAR as a prognostic biomarker in sepsis
Katia Donadello1, Sabino Scolletta, Cecilia Covajes
1Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, 808, route de Lennik 1070, Brussels, Belgium.
BMC Medicine
|January 7, 2012
Summary
Soluble urokinase-type plasminogen activator receptor (suPAR) shows promise as a biomarker for sepsis diagnosis and prognosis. Further research is needed to define its clinical utility compared to established markers like CRP and PCT.
Area of Science:
- Biochemistry
- Critical Care Medicine
- Immunology
Background:
- Sepsis is a life-threatening condition caused by the host response to infection, representing a leading cause of death in critically ill patients.
- Various biomarkers are used for sepsis diagnosis and prognosis, but their clinical utility varies.
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in infectious diseases and has shown potential in predicting outcomes.
Purpose of the Study:
- To review the clinical value of suPAR in sepsis.
- To evaluate suPAR's diagnostic and prognostic capabilities.
- To compare suPAR with established sepsis biomarkers and severity scores.
Main Methods:
- Narrative review of existing literature.
- Analysis of studies investigating suPAR in sepsis diagnosis and prognosis.
- Comparison of suPAR performance against C-reactive protein (CRP) and procalcitonin (PCT).
Main Results:
- suPAR levels are increased in sepsis and various infectious conditions.
- The diagnostic value of suPAR in sepsis requires further definition, especially in comparison to CRP and PCT.
- suPAR demonstrates predictive value for outcomes in bacteremia and critically ill patients, potentially similar to severity scores.
Conclusions:
- suPAR is a promising biomarker for sepsis.
- Its role in diagnosis, prognosis, and guiding therapy warrants further investigation.
- suPAR may offer valuable insights into patient outcomes in critical care settings.
